---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-091893"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2026-08-20T11:43:35+00:00"
generated_at: "2026-08-20T11:45:08.217552+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fortitude Q2 revenue $20.9M, adj EBITDA $8.5M; buys 9.4% HSCS stake ahead of merger

## Summary
- Fortitude Q2 2026 revenue $20.9M; adjusted EBITDA $8.5M.
- Mined ~33,646 ZEC at 4.0 GSol/s avg hash rate; 60+ MW across 7 sites.
- On Aug 12, 2026 Fortitude bought 411,522 HSCS shares at $2.43 VWAP (22% premium), now owns ~9.4%.
- Proposed merger with HeartSciences expected to close H2 2026; exchange ratio unchanged.

## SEC filing metadata
- accession: 0001213900-26-091893
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2026-08-20T11:43:35+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390026091893/0001213900-26-091893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390026091893/ea0302835-8k_heart.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-091893
- JSON: https://secwatch.observer/filing/0001213900-26-091893.json
- Plain text: https://secwatch.observer/filing/0001213900-26-091893.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.